Athersys Inc (ATHXQ)

[goupupup]

This is ANOTHER good reason to REMAIN BULLISH .. 1st 60% of ALLLLL phase 3 trials advance. That’s NOT a bad success rate, also the FDA pointed out two main reasons for Phase 3 failures (among others): Use of biomarkers in Phase 2 that did not accurately predict the Phase 3 outcome (e.g., oncology and cardiovascular disease) Untested mechanism of action.” Bio markers are well documented in Multistem and the mechanism is better understood. It’s not that we just think it works but also understand why it works, which is why they were able to tweak the treatment window to maximize success potential. This puts us in more of the 80-90% chance of success range .. We will know soon enough ... GOOD LUCK LONGS

https://www.nuventra.com/resources/blog/placebo-response-phase-3-failures/